{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:51:01Z","timestamp":1784739061629,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rembrandt Institute of Cardiovascular Science (RICS)"},{"name":"Netherlands Heart Foundation","award":["2012T051"],"award-info":[{"award-number":["2012T051"]}]},{"name":"Netherlands Heart Foundation","award":["2009T038"],"award-info":[{"award-number":["2009T038"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.atherosclerosis.2016.05.031","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T04:58:46Z","timestamp":1463806726000},"page":"6-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice"],"prefix":"10.1016","volume":"251","author":[{"given":"Andrea D.","family":"van Dam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siroon","family":"Bekkering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-5194","authenticated-orcid":false,"given":"Malou","family":"Crasborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vrieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"van Harmelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno P.J.","family":"de Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"L\u00fctjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte R.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels P.","family":"Riksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy F.P.","family":"Berb\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1160\/TH11-06-0392","article-title":"Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis","volume":"106","author":"Rosenfeld","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib3","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1161\/CIRCULATIONAHA.107.693382","article-title":"Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice","volume":"116","author":"Westerterp","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2217\/imt.15.60","article-title":"Strategies to improve BCG vaccine efficacy","volume":"7","author":"Bali","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(98)00284-6","article-title":"Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit","volume":"143","author":"Lamb","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/joim.12127","article-title":"Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis","volume":"275","author":"Ovchinnikova","year":"2014","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib7","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice","volume":"26","author":"Westerterp","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2007.08.001","article-title":"Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice","volume":"197","author":"de Haan","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib9","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/ncomms7356","article-title":"Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development","volume":"6","author":"Berbee","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib10","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00443216","article-title":"Generalized lymphadenitis following B.C.G. vaccination in an immunocompetent 12-year-old boy","volume":"141","author":"Katzir","year":"1984","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5144\/0256-4947.2013.627","article-title":"Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guerin vaccination","volume":"33","author":"Shoaran","year":"2013","journal-title":"Ann. Saudi. Med."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.2015.1024656","article-title":"Intravesical therapy for bladder cancer","volume":"16","author":"Patel","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1155\/2000\/409570","article-title":"Hepatitis in disseminated bacillus Calmette-Guerin infection","volume":"14","author":"Gottke","year":"2000","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib16","article-title":"Macronodular hepatosplenic tuberculosis","volume":"1","author":"Guidi","year":"2012","journal-title":"Acta Radiol. Short. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib17","doi-asserted-by":"crossref","first-page":"353798","DOI":"10.1155\/2013\/353798","article-title":"Unusual manifestation of extrapulmonary tuberculosis","volume":"2013","author":"Alghamdi","year":"2013","journal-title":"Case. Rep. Med."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2217\/clp.14.50","article-title":"The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis","volume":"9","author":"Getz","year":"2014","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tim.2011.07.009","article-title":"Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis","volume":"19","author":"Ouellet","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10409238.2014.895700","article-title":"Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis","volume":"49","author":"Wipperman","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib21","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.0711159105","article-title":"Mycobacterial persistence requires the utilization of host cholesterol","volume":"105","author":"Pandey","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mib.2015.10.002","article-title":"Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection","volume":"29","author":"Lovewell","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib23","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1073\/pnas.79.12.3823","article-title":"Cholesterol synthesis in polyclonally activated cytotoxic lymphocytes and its requirement for differentiation and proliferation","volume":"79","author":"Heiniger","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/eji.1830101105","article-title":"Plasma membrane cholesterol regulates human lymphocyte cytotoxic function","volume":"10","author":"Dabrowski","year":"1980","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1126\/science.288.5471.1647","article-title":"Essential role for cholesterol in entry of mycobacteria into macrophages","volume":"288","author":"Gatfield","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cmi.12279","article-title":"Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment","volume":"16","author":"Mattos","year":"2014","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201000079","article-title":"Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism","volume":"2","author":"Kim","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bpg.2016.03.001","article-title":"Acquired causes of intestinal malabsorption","volume":"30","author":"van der Heide","year":"2016","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcf.2011.03.008","article-title":"Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice","volume":"10","author":"Wouthuyzen-Bakker","year":"2011","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib30","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-1151","article-title":"Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols","author":"Gelzo","year":"2016","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib31","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/ajcn\/32.12.2540","article-title":"Serum cholesterol and diseases in Nigerians","volume":"32","author":"Taylor","year":"1979","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clinbiochem.2006.10.015","article-title":"Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis","volume":"40","author":"Deniz","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib33","doi-asserted-by":"crossref","first-page":"e1002093","DOI":"10.1371\/journal.ppat.1002093","article-title":"Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages","volume":"7","author":"Daniel","year":"2011","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib34","doi-asserted-by":"crossref","first-page":"e40221","DOI":"10.1371\/journal.pone.0040221","article-title":"Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients","volume":"7","author":"Weiner","year":"2012","journal-title":"PLoS. One."},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.103.8.1064","article-title":"Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study","volume":"103","author":"Kiechl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.05.031_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2006.01.008","article-title":"Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patients","volume":"190","author":"Giral","year":"2007","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T13:31:03Z","timestamp":1531402263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016302088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"alternative-id":["S0021915016302088"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.05.031","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}